share_log

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scott John K Jr.

SEC ·  Jun 30, 2023 22:46
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more